Mometasona Ratiopharm (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Ratiopharm, is a corticosteroid presented as a topical formulation for skin use. It is employed to manage inflammatory dermatoses such as psoriasis, atopic dermatitis, allergic contact dermatitis and seborrheic dermatitis, reducing redness, scaling and itching in affected patients.

GNH USA supplies Mometasona Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a potent topical corticosteroid used to treat inflammatory skin conditions. - Psoriasis: reduces inflammation and scaling, improving skin appearance. - Atopic dermatitis: alleviates itching and erythema, restoring barrier function. - Allergic contact dermatitis: suppresses allergic inflammation and relieves symptoms. - Seborrheic dermatitis: controls flaking and redness on scalp and facial areas.

Topical application of mometasone furoate may cause local skin reactions and, rarely, systemic effects.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Dryness or flaking of the skin. - Erythema or mild redness. - Folliculitis or small pimples. - Skin irritation or contact dermatitis.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Secondary bacterial, fungal or viral infection of the treated area. - Hypersensitivity reactions such as urticaria or angioedema. - Systemic corticosteroid effects (e.g., adrenal suppression) after extensive application. - Delayed wound healing. - Hypertrichosis (excessive hair growth) in the treated region.

When using Mometasona Ratiopharm, consider the following precautions to ensure safe and effective therapy. - Assess severity: limit use to mild‑moderate disease and avoid prolonged continuous application. - Avoid occlusion: do not cover treated skin with airtight dressings unless directed by a clinician. - Monitor for infection: discontinue if signs of bacterial, fungal or viral infection develop. - Use minimal amount: apply the thinnest film necessary to cover the affected area. - Pediatric use: exercise caution in children due to higher per‑body‑surface absorption. - Store at room temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mometasone furoate may interact with other agents that affect corticosteroid activity or skin integrity.

Major Interactions (Avoid):\n- Systemic corticosteroids: additive systemic glucocorticoid effects may increase risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug concentration, enhancing side‑effects.

Moderate Interactions (Monitor Closely): - Topical antifungal agents: concurrent use may increase irritation risk. - Antibiotic creams or ointments: may alter skin flora and affect healing. - Phototherapy: combined use can heighten skin sensitivity to light. - Other potent topical steroids: may cause excessive local immunosuppression. - Skin barrier‑disrupting products (e.g., harsh cleansers): can increase absorption and irritation.